The document discusses new regulations from the Drug Regulatory Authority of Pakistan (DRAP) regarding acetaminophen in combination drug products. DRAP is limiting acetaminophen to 325mg per dosage unit and requiring warning labels about risks of severe liver injury and allergic reactions. This action follows a review by the US FDA that found acetaminophen overdoses can cause liver damage and fail